FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19
April 04, 2020
April 04, 2020
WASHINGTON, April 4 -- The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release:
The U.S. Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19. As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two investigational therapies derived from human blood. These are . . .
The U.S. Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19. As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two investigational therapies derived from human blood. These are . . .